HDAC9 and autosomal dominant polycystic kidney disease: Two of these compounds, the class I HDAC inhibitor, VPA, and class I and II inhibitor, TSA, have both been shown to reduce cyst formation and slow cyst growth in animal models of ADPKD [55,56,62,63,64].